Predictive factors for exudation of quiescent choroidal neovessels detected by OCT angiography in the fellow eyes of eyes treated for a neovascular age-related macular degeneration.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
24
09
2019
accepted:
27
04
2020
revised:
30
03
2020
pubmed:
14
5
2020
medline:
22
6
2021
entrez:
14
5
2020
Statut:
ppublish
Résumé
To identify predictive factors for exudation for quiescent choroidal neovessels (qCNV) in the fellow eyes of eyes treated for a neovascular age-related macular degeneration (AMD). Prospective observational study. One hundred and forty-four contralateral eyes of 144 patients treated for wet AMD were analysed. At a baseline visit, multimodal imaging including dye angiographies and optical coherence tomography angiography (OCT-A) was performed in order to detect qCNV. Patients were followed up for 12 months with a monthly assessment. The manifestation of any type of exudation (either intra- or subretinal fluid or hyperreflective subretinal material) was monitored. The prevalence of qCNV in the treatment-naive eyes was 15.9% with an incidence over a 12-month period of 2.8%. In total, 40.7% of the overall neovessels remained stable with no sign of exudation, while 59.3% presented some fluid during the follow-up. A statistically significant relationship was established for the following variables preceding the exudation: increase in central macular thickness (OR = 116; 95% CI [4.74; 50530] p = 0.038), increase in pigment epithelial detachment height (OR = 1.76; 95% CI [1.17; 3.18] p = 0.021) and width (OR = 1.53; 95% CI [1.12; 2.62] p = 0.042), increase in neovessels' surface on OCT-A (OR = 6.32; 95% CI [1.62; 51.0] p = 0.033), emergence of a branching pattern (OR = 7.50; 95% CI[1.37; 61.5] p = 0.032) and appearance of a hypointense halo surrounding the lesion (OR = 10.00; 95% CI [1.41; 206] p = 0.048). The risk of exudation in the treatment-naive fellow eyes of eyes treated for neovascular AMD was notably increased in the presence of qCNV. The biomarkers identified will help to detect their activation in order to ensure prompt antiangiogenic therapy.
Sections du résumé
BACKGROUND
To identify predictive factors for exudation for quiescent choroidal neovessels (qCNV) in the fellow eyes of eyes treated for a neovascular age-related macular degeneration (AMD).
METHODS
Prospective observational study. One hundred and forty-four contralateral eyes of 144 patients treated for wet AMD were analysed. At a baseline visit, multimodal imaging including dye angiographies and optical coherence tomography angiography (OCT-A) was performed in order to detect qCNV. Patients were followed up for 12 months with a monthly assessment. The manifestation of any type of exudation (either intra- or subretinal fluid or hyperreflective subretinal material) was monitored.
RESULTS
The prevalence of qCNV in the treatment-naive eyes was 15.9% with an incidence over a 12-month period of 2.8%. In total, 40.7% of the overall neovessels remained stable with no sign of exudation, while 59.3% presented some fluid during the follow-up. A statistically significant relationship was established for the following variables preceding the exudation: increase in central macular thickness (OR = 116; 95% CI [4.74; 50530] p = 0.038), increase in pigment epithelial detachment height (OR = 1.76; 95% CI [1.17; 3.18] p = 0.021) and width (OR = 1.53; 95% CI [1.12; 2.62] p = 0.042), increase in neovessels' surface on OCT-A (OR = 6.32; 95% CI [1.62; 51.0] p = 0.033), emergence of a branching pattern (OR = 7.50; 95% CI[1.37; 61.5] p = 0.032) and appearance of a hypointense halo surrounding the lesion (OR = 10.00; 95% CI [1.41; 206] p = 0.048).
CONCLUSIONS
The risk of exudation in the treatment-naive fellow eyes of eyes treated for neovascular AMD was notably increased in the presence of qCNV. The biomarkers identified will help to detect their activation in order to ensure prompt antiangiogenic therapy.
Identifiants
pubmed: 32398845
doi: 10.1038/s41433-020-0936-7
pii: 10.1038/s41433-020-0936-7
pmc: PMC8027175
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
644-650Références
Augood CA, Vingerling JR, de Jong PTVM, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol. 2006;124:529–35.
doi: 10.1001/archopht.124.4.529
Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Prevalence of age- related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72.
doi: 10.1001/archopht.122.7.1019
Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–e116.
doi: 10.1016/S2214-109X(13)70145-1
Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–2.
doi: 10.1001/archopht.1984.01040031330019
Chopra R, Wagner SK, Fasler K, Kortuem KU, Pontikos N, Afshar F, et al. Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital. Investig Ophthalmol Vis Sci. 2018;59:816–816.
Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121:1435–44.
doi: 10.1016/j.ophtha.2014.01.034
Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH. Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina. 2015;35:2219–28.
doi: 10.1097/IAE.0000000000000766
Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1–55.
doi: 10.1016/j.preteyeres.2017.11.003
Roisman L, Goldhardt R. OCT angiography: an upcoming non-invasive tool for diagnosis of age-related macular degeneration. Curr Ophthalmol Rep. 2017;5:136–40.
doi: 10.1007/s40135-017-0131-6
Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol. 2015;133:629–30.
doi: 10.1001/jamaophthalmol.2015.0668
de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retin Vitreous. 2015;1:5.
doi: 10.1186/s40942-015-0005-8
Faridi A, Jia Y, Gao SS, Huang D, Bhavsar KV, Wilson DJ, et al. Sensitivity and specificity of OCT angiography to detect choroidal neovascularization. Ophthalmol Retin. 2017;1:294–303.
doi: 10.1016/j.oret.2017.02.007
Querques G, Srour M, Massamba N, Georges A, Ben Moussa N, Rafaeli O, et al. Functional characterization and multimodal imaging of treatment-naive ‘quiescent’ choroidal neovascularization. Investig Ophthalmol Vis Sci. 2013;54:6886–92.
doi: 10.1167/iovs.13-11665
Carnevali A, Cicinelli MV, Capuano V, Corvi F, Mazzaferro A, Querques L, et al. Optical coherence tomography angiography: a useful tool for diagnosis of treatment-naïve quiescent choroidal neovascularization. Am J Ophthalmol. 2016;169:189–98.
doi: 10.1016/j.ajo.2016.06.042
de Oliveira Dias JR, Zhang Q, Garcia JMB, Zheng F, Motulsky EH, Roisman L, et al. Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography. Ophthalmology. 2018;125:255–66.
doi: 10.1016/j.ophtha.2017.08.030
Carnevali A, Sacconi R, Querques L, Marchese A, Capuano V, Rabiolo A, et al. Natural history of treatment-naïve quiescent choroidal neovascularization in age-related macular degeneration using oct angiography. Ophthalmol Retin. 2018;2:922–30.
doi: 10.1016/j.oret.2018.02.002
Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015;160:739–48.e2.
doi: 10.1016/j.ajo.2015.06.030
El Ameen A, Cohen SY, Semoun O, Miere A, Srour M, Quaranta-El Maftouhi M, et al. TYPE 2 neovascularization secondary to age-related macular degeneration imaged by optical coherence tomography angiography. Retina. 2015;35:2212–8.
doi: 10.1097/IAE.0000000000000773
Miere A, Querques G, Semoun O, El Ameen A, Capuano V, Souied EH. Optical coherence tomography angiography in early type 3 neovascularization. Retina. 2015;35:2236–41.
doi: 10.1097/IAE.0000000000000834
Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography.Retina. 2018;38:220–30.
doi: 10.1097/IAE.0000000000001628
Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen C-L, et al. Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology. 2016;123:1309–19.
doi: 10.1016/j.ophtha.2016.01.044
Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS, et al. Detection of non-exudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina. 2015;35:2204–11.
doi: 10.1097/IAE.0000000000000867
Capuano V, Miere A, Querques L, Sacconi R, Carnevali A, Amoroso F, et al. Treatment-naïve quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration. Am J Ophthalmol. 2017;182:45–55.
doi: 10.1016/j.ajo.2017.07.009
Nehemy MB, Brocchi DN, Veloso CE. Optical coherence tomography angiography imaging of quiescent choroidal neovascularization in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retin. 2015;46:1056–7.
doi: 10.3928/23258160-20151027-13
Schneider U, Gelisken F, Inhoffen W, Kreissig I. Indocyanine green angiographic findings in fellow eyes of patients with unilateral occult neovascular age-related macular degeneration. Int Ophthalmol. 1997;21:79–85.
doi: 10.1023/A:1005848806641
Rispoli M, Savastano MC, Lumbroso B. Quantitative vascular density changes in choriocapillaris around CNV after Anti-VEGF treatment: dark halo. Ophthalmic Surg Lasers Imaging Retin. 2018;49:918–24.
doi: 10.3928/23258160-20181203-02
Xu D, Dávila JP, Rahimi M, Rebhun CB, Alibhai AY, Waheed NK, et al. Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography. Am J Ophthalmol. 2018;187:10–20.
doi: 10.1016/j.ajo.2017.12.005